Similarly, although Ki67 is not currently used as a thoracic WHO criterion, the Ki67 rate of 20–30% (30% in the current WHO) is generally regarded as a ceiling rate for lung carcinoids. Here, MKI67 is linked to lung carcinoid tumor.